VASCOMATH- India’s first human biology model that evaluates molecular mechanisms to predict onset & progression of cardiovascular diseases

New Delhi: Genefitletics, which envisions placing chronic diseases in history books, not in lives of current & future generations, has launched VASCOMATH – India’s first microbiome driven human biology model to predict cardiovascular diseases based on gut & oral microbiome gene expression.

With the endeavour to predict & early detect chronic diseases & provide interventions that can eliminate molecules involved in disease or infection using nutrition as medicine so that disease do not even develop, VASCOMATH is the perfect addition to its suite of predictive human biology models. The company launched its type 2 diabetes prediction model- PREDIGLYM couple of months back.

Founded in 2019, Genefitletics developed India’s first system biology- PROTEBA that measures chemistry at molecular level & analyses it using machine learning to provide disease modifying nutrition therapeutics interventions in order to restore human health.

Sushant Kumar, Founder & CEO- Genefitletics quotes “Cardiovascular is the leading cause of deaths globally with around 17.9 million lives dying of this preventable disease. In India alone, 27% of the deaths are attributed to heart diseases. We have all science & technology in place to prevent disease, prevent & cure cardiovascular diseases, yet the number of people suffering from chronic diseases is increasing day by day. The current industrial healthcare system, instead of determining the underlying cause of cardiovascular disease, adopts a pharmaceutical approach to suppress cholesterol which is counter intuitive since our body needs cholesterol to perform various biological functions including making Vitamin D,Bile acid & various hormones.”

He further adds, “Missing piece in the heart puzzle is the long-ignored aspect- MICROBIOME, the first inhabitant on planet earth. Over the last few years, Scientific investigations are focussed on exploring the role of trillions of microbes living inside the human body on our health. It is important to understand that an individual does not develop cardiovascular disease overnight. It starts with chronic inflammation which triggers pro-inflammatory molecular indications about 20 years ago. Unfortunately, these molecular signatures are completely invisible & cannot be measured using traditional clinical grade tests or diagnostic investigations. These molecular signatures occur due to alteration in gene expression of gut or oral microbial genes expression.”

Genefitletics’s platform PROTEBA blends system biology & machine learning that processes and analyses billions of molecular data points coming from oral, vaginal & gut microbiome genes expression to build prediction models that identifies & measures pre-symptomatic molecular signatures predictive of chronic disease via 50 plus biological pathways/biomarkers & then eliminate these proinflammatory molecules via curating precision nutrition interventions so that no one is diagnosed with the disease.